BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1912561)

  • 1. Platelet activation by a synthetic hydrophobic polymer, polymethylmethacrylate.
    Ware JA; Kang J; DeCenzo MT; Smith M; Watkins SC; Slayter HS; Saitoh M
    Blood; 1991 Oct; 78(7):1713-21. PubMed ID: 1912561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activation and subsequent inhibition by plasmin and recombinant tissue-type plasminogen activator.
    Penny WF; Ware JA
    Blood; 1992 Jan; 79(1):91-8. PubMed ID: 1530814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
    Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J
    Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human platelet activation is inhibited by the occupancy of glycoprotein IIb/IIIa receptor.
    Padoin E; Alexandre A; Cavallini L; Polverino de Laureto P; Rao GH; Doni MG
    Arch Biochem Biophys; 1996 Sep; 333(2):407-13. PubMed ID: 8809080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a role of glycoprotein IIb-IIIa, distinct from its ability to support aggregation, in platelet activation by ionophores in the presence of extracellular divalent cations.
    Lages B; Weiss HJ
    Blood; 1994 May; 83(9):2549-59. PubMed ID: 8167340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex.
    Coller BS
    J Clin Invest; 1985 Jul; 76(1):101-8. PubMed ID: 2991335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.
    Huang TF; Liu CZ; Ouyang CH; Teng CM
    Biochem Pharmacol; 1991 Aug; 42(6):1209-19. PubMed ID: 1888330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation.
    Peerschke EI
    J Lab Clin Med; 1985 Aug; 106(2):111-22. PubMed ID: 2991399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin.
    Chen J; Herceg-Harjacek L; Groopman JE; Grabarek J
    Blood; 1995 Dec; 86(11):4054-62. PubMed ID: 7492761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIa.
    Niewiarowski S; Kornecki E; Hershock D; Tuszynski GP; Bennett JS; Soria C; Soria J; Dunn F; Pidard D; Kieffer N
    J Lab Clin Med; 1985 Dec; 106(6):651-60. PubMed ID: 2999274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical localization of fibrinogen on washed human platelets. Lack of requirement for fibrinogen during adenosine diphosphate-induced responses and enhanced fibrinogen binding in a medium with low calcium levels.
    Suzuki H; Kinlough-Rathbone RL; Packham MA; Tanoue K; Yamazaki H; Mustard JF
    Blood; 1988 Apr; 71(4):850-60. PubMed ID: 2833330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction.
    Mazoyer E; Lévy-Toledano S; Rendu F; Hermant L; Lu H; Fiat AM; Jollès P; Caen J
    Eur J Biochem; 1990 Nov; 194(1):43-9. PubMed ID: 2174781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex.
    Huang TF; Holt JC; Lukasiewicz H; Niewiarowski S
    J Biol Chem; 1987 Nov; 262(33):16157-63. PubMed ID: 3680247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A peptide ligand of the human thrombin receptor antagonizes alpha-thrombin and partially activates platelets.
    Rasmussen UB; Gachet C; Schlesinger Y; Hanau D; Ohlmann P; Van Obberghen-Schilling E; Pouysségur J; Cazenave JP; Pavirani A
    J Biol Chem; 1993 Jul; 268(19):14322-8. PubMed ID: 8390990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of fibrinogen and platelet membrane glycoprotein IIb/IIIa in shear-induced platelet aggregation.
    Ikeda Y; Murata M; Araki Y; Watanabe K; Ando Y; Itagaki I; Mori Y; Ichitani M; Sakai K
    Thromb Res; 1988 Jul; 51(2):157-63. PubMed ID: 3187957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycoprotein IIb-IIIa-liposomes bind fibrinogen but do not undergo fibrinogen-mediated aggregation.
    Sloan SM; Brown EB; Liu Q; Frojmovic MM
    Platelets; 2000 Mar; 11(2):99-110. PubMed ID: 10938888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of human platelet activation by endotoxic glycolipid-bearing mutant Re595 of Salmonella minnesota.
    Timmons S; Huzoor-Akbar ; Grabarek J; Kloczewiak M; Hawiger J
    Blood; 1986 Nov; 68(5):1015-23. PubMed ID: 3768528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure of platelet fibrinogen receptors by zinc ions: role of protein kinase C.
    Trybulec M; Kowalska MA; McLane MA; Silver L; Lu W; Niewiarowski S
    Proc Soc Exp Biol Med; 1993 May; 203(1):108-16. PubMed ID: 8475131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine phosphorylation of the novel protein-tyrosine kinase RAFTK during an early phase of platelet activation by an integrin glycoprotein IIb-IIIa-independent mechanism.
    Raja S; Avraham S; Avraham H
    J Biol Chem; 1997 Apr; 272(16):10941-7. PubMed ID: 9099753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinogen fragments and platelet dysfunction in uremia.
    Kozek-Langenecker SA; Masaki T; Mohammad H; Green W; Mohammad SF; Cheung AK
    Kidney Int; 1999 Jul; 56(1):299-305. PubMed ID: 10411706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.